BYDROGEN LIMITED

Company Registration Number:
SC794526 (Scotland)

Unaudited statutory accounts for the year ended 31 January 2025

Period of accounts

Start date: 09 January 2024

End date: 31 January 2025

BYDROGEN LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

BYDROGEN LIMITED

Company Information

for the Period Ended 31 January 2025




Director: Adebayo Aremu
Oyinkansola Aremu
Registered office: 272
Bath Street
Glasgow
GB-SCT
G2 4JR
Company Registration Number: SC794526 (Scotland)

BYDROGEN LIMITED

Directors' Report Period Ended 31 January 2025

The directors present their report with the financial statements of the company for the period ended 31 January 2025

Directors

The director(s) shown below were appointed to the company during the period
Adebayo Aremu
09 January 2024
Oyinkansola Aremu
09 January 2024

This report was approved by the board of directors on 22 September 2025
And Signed On Behalf Of The Board By:

Name: Adebayo Aremu
Status: Director

Name: Oyinkansola Aremu
Status: Director

BYDROGEN LIMITED

Profit and Loss Account

for the Period Ended 31 January 2025


Notes
13 months to
31 Jan 2025
£
Administrative Expenses ( 14,204 )
Operating Profit or (Loss) ( 14,204 )
Profit or (Loss) Before Tax ( 14,204 )
Profit or (Loss) for Period ( 14,204 )

The notes form part of these financial statements

BYDROGEN LIMITED

Balance sheet

As at 31 January 2025


Notes
13 months to
31 Jan 2025
£
Fixed assets
Total fixed assets: -
Current assets
Cash at bank and in hand: 146
Total current assets: 146
Creditors: amounts falling due within one year: 4 ( 14,250 )
Net current assets (liabilities): ( 14,104 )
Total assets less current liabilities: ( 14,104 )
Total net assets (liabilities): ( 14,104 )

The notes form part of these financial statements

BYDROGEN LIMITED

Balance sheet continued

As at 31 January 2025


Notes
13 months to
31 Jan 2025
£
Capital and reserves
Called up share capital: 100
Profit and loss account: ( 14,204 )
Shareholders funds: ( 14,104 )

For the year ending 31 January 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 22 September 2025
And Signed On Behalf Of The Board By:

Name: Adebayo Aremu
Status: Director

Name: Oyinkansola Aremu
Status: Director

The notes form part of these financial statements

BYDROGEN LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BYDROGEN LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2025

  • 2. Employees

    13 months to
    31 Jan 2025
    Average number of employees during the period 0

BYDROGEN LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2025

  • 3. Off balance sheet disclosure

    No

BYDROGEN LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2025

4.Creditors: amounts falling due within one year note

13 months to
31 Jan 2025
£
Other creditors 14,250
Total 14,250